Together we're advancing
women's health

Meet our team

Founded in 2009, Celmatix is a personalized medicine company focused on fertility and women’s health. Our technology-enabled products empower people, through better data, to dramatically improve their chances of conceiving.


Celmatix is leading the revolution in personalizing reproductive medicine. Read more in the stories below on our press page.
Fortune Magazine
“This Entrepreneur Is Using Big Data to Help More Women Get Pregnant”
Read article
tech crunch
23andMe and Women’s Health Startup Celmatix Combine Forces To Research Genes Affecting Infertility
Read article

How Celmatix Uses Big Data to Treat Infertility

Celmatix CEO Piraye Yurttas Beim discusses how big data is used to treat infertility with Emily Chang on Bloomberg West.
Watch video

Meet the team

Team Celmatix is headquartered in the heart of New York City’s Financial District. Learn more about our growing team working towards advancing personalized medicine and women’s health.

Team Celmatix

Celmatix’s team includes a diverse group of world-class professionals and scientists, including those with backgrounds in bioinformatics, statistics, and data science


Powering fundamental research discoveries and then rapidly translating those breakthroughs to significantly impact patient outcomes


Supporting and expanding our world-class digital platform and powering digital tools that transform the patient and physician experience

Clinical Laboratory

Celmatix’s Brooklyn-based clinical sequencing laboratory powers the company’s genetic screening panels

Product & Marketing

Building world class human-centered digital products, with an emphasis on design and user experience

Data Science

Leveraging large clinical and genetic datasets to make a meaningful impact on women’s health


Working with top fertility clinics across the country to integrate our best-in-class digital platform


Supporting the entire organization's clinical, legal, and financial infrastructure
Groundbreaking genomic discoveries
Digital platform development
Clinical Laboratory
Overseeing the genetic testing facility
Product & Marketing
Design & positioning of product suite
Data Science
Providing insights into clinical data
Driving strategic business development
Supporting clinical, legal, & financial infrastructure

Leadership team

Piraye Yurttas Beim, PhD

Founder & CEO

Dr. Piraye Yurttas Beim founded Celmatix in 2009 to empower women to be more proactive and informed about their fertility through better data, including genomics. She was on the front lines of the personalized medicine revolution during her doctoral work at MSKCC/Weill Cornell (NYC) and was inspired to create the company after completing her postdoctoral embryology research training at the University of Cambridge (UK). Realizing how many of the successful and career-minded women in her network were making major, life-defining decisions around fertility based on age alone, she set out to bring personalized medicine to reproductive health. In addition to her scientific credentials, Dr. Beim has also been widely recognized as an emerging business leader. She is a Fellow of the second class of the Aspen Institute Health Innovators Fellowship program, a member of the Aspen Global Leadership Network, and was named a NYC Venture Fellow by the NYCEDC, to Crain’s 40 Under 40, Top 15 founders disrupting their industries by Fortune, and a Top Female Founder by TechCrunch. She lives in New York City with her husband and three children.

Lori Batta

Chief Commercial Officer at Celmatix

Lori Batta is the Chief Commercial Officer at Celmatix, where she oversees the sales and customer support functions as well as leads strategic alliances. She is a seasoned healthcare executive with more than 25 years of experience, previously serving as Senior Vice President, Business Development and Strategic Alliances, at Good Start Genetics, Inc. (GSG), a pioneering genetic testing company, where she led the company’s global business development strategy. During her time at GSG, she was responsible for the launch of the first next-generation sequencing carrier screen and drove more than $100M in revenue in its first three years on the market. She has also held senior roles at MDR Specialty Pharmacy, EMD Serono, and Novartis. Lori received her BA in Biology from the College of St. Elizabeth and has earned certifications in business and leadership from Babson College and Wharton Business School. She lives outside of Boston with her wife and two daughters.

Richard Hofbauer

Chief Operating Officer

Richard Hofbauer is Chief Operating Officer (COO) and interim Chief Financial Officer (CFO) at Celmatix. As a leader, Rich brings to Celmatix a unique blend of operational discipline and experience with raising capital, scaling, and organizational development. Prior to Celmatix, he was COO at Intersection, Inc., having previously served as a Partner at Control Group (which later merged with Titan360 to form Intersection). While at Control Group, he helped attract Fortune 500 clients, improve profitability and revenue, and successfully positioned the organization for investment from Sidewalk Labs, an Alphabet company, alongside private investors. Before that, he was the first employee hired at MortgageIT Holdings (MHL), which grew to 2,500 employees before going public and being acquired by Deutsche Bank in 2006. Rich is a graduate of the University at Buffalo, where he earned a bachelor’s degree in Environmental Design. He lives in New Jersey with his wife, son, and daughter.

Ali Siam

Senior Vice President, Business Development

Ali Siam is the Senior Vice President of Business Development at Celmatix, where he leads strategic partnerships with stakeholders across the reproductive health ecosystem and strategy development for the Biosciences division. Ali brings to Celmatix a unique blend of strategic planning and operating experience across verticals and functional areas in healthcare. Prior to joining Celmatix, he led corporate strategy, R&D prioritization, portfolio strategy, and due diligence engagements for large pharmaceutical, diagnostic, healthcare services, biotech, and institutional investor clients as a team leader at L.E.K. Consulting. He also led collaborations with digital health and bioinformatic startups at AbbVie, in addition to holding marketing and R&D roles at Johnson & Johnson, and Boston Scientific. He holds an MBA from Boston College and a BS in Mechanical Engineering from Northeastern University. He lives near Boston with his wife and three children.

Advisory board

Laura Towart, MSc
Founder and director
Steve Winick
Mark Adams, PhD
Scientific advisory board
Gurinder Singh “Mickey” Atwal, PhD
Scientific advisory board
Aaron B. Caughey MD, PhD
Scientific advisory board
Amber R. Cooper, MD, MSCI
Scientific advisory board
Alan Copperman, MD
Scientific advisory board
Michael Elashoff, PhD
Scientific advisory board
Linda C. Giudice, MD, PhD
Scientific advisory board
James Hicks, PhD
Scientific advisory board
Dolores J. Lamb, PhD, HCLD
Scientific advisory board
Georgia Witkin, PhD
Emeritus scientific advisor
Ardy Arianpour
Corporate advisory board
Christina Carlisle Jones
Corporate advisory board
Cory Onderejka
Corporate advisory board
Halle Tecco
Corporate advisory board
Greg Yap
Corporate advisory board
Angie Lee
Corporate advisory board

Join our team